U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C3H7NO2
Molecular Weight 89.0932
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALANINE, DL-

SMILES

CC(N)C(O)=O

InChI

InChIKey=QNAYBMKLOCPYGJ-UHFFFAOYSA-N
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.
2001-05-18
An intrahelical salt bridge within the trigger site stabilizes the GCN4 leucine zipper.
2001-04-27
Different usage of the glycosaminoglycan attachment sites of biglycan.
2001-04-20
Characterization of a phospholipase C beta 2-binding site near the amino-terminal coiled-coil of G protein beta gamma subunits.
2001-04-06
Disruption of an active site hydrogen bond converts human heme oxygenase-1 into a peroxidase.
2001-04-06
The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity.
2001-04-06
Interacting fidelity defects in the replicative DNA polymerase of bacteriophage RB69.
2001-03-30
Construction of a high affinity zinc binding site in the metabotropic glutamate receptor mGluR1: noncompetitive antagonism originating from the amino-terminal domain of a family C G-protein-coupled receptor.
2001-03-30
Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanism.
2001-03-30
Scanning mutagenesis reveals roles for helix n of the bacteriophage T7 RNA polymerase thumb subdomain in transcription complex stability, pausing, and termination.
2001-03-30
Role of two histidines in the (6-4) photolyase reaction.
2001-03-30
Hydrogen exchange nuclear magnetic resonance spectroscopy mapping of antibody epitopes on the house dust mite allergen Der p 2.
2001-03-23
The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains.
2001-03-23
Roles for the C-terminal region of sigma 54 in transcriptional silencing and DNA binding.
2001-03-23
Requirements and effects of palmitoylation of rat PLD1.
2001-03-23
Functional rescue of the nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutants G185C and R202C by a second site suppressor mutation.
2001-03-16
The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD.
2001-03-16
Regulation of ROMK1 channels by protein-tyrosine kinase and -tyrosine phosphatase.
2001-03-09
Mutagenic analysis of functional residues in putative substrate-binding site and acidic domains of vacuolar H+-pyrophosphatase.
2001-03-09
Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1).
2001-01-26
The PD...(D/E)XK motif in restriction enzymes: a link between function and conformation.
2001-01-16
Substituting leucine for alanine-86 in the tether region of the iron-sulfur protein of the cytochrome bc1 complex affects the mobility of the [2Fe2S] domain.
2001-01-16
Short, solubilized polyalanines are conformational chameleons: exceptionally helical if N- and C-capped with helix stabilizers, weakly to moderately helical if capped with rigid spacers.
2001-01-16
Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis.
2001-01-12
Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites.
2001-01-09
Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patients.
2001-01-05
The role of nitric oxide in bradycardia of rats with obstructive cholestasis.
2001-01-05
Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chirality.
2001-01-01
Ligand binding to integrin alpha(v)beta(3) requires tyrosine 178 in the alpha(v) subunit.
2001-01-01
Microdialysis study of amino acid neurotransmitters in the spinal dorsal horn of patients undergoing microsurgical dorsal root entry zone lesioning. Technical note.
2001-01
Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome.
2001-01
Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis.
2001-01
Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.
2001-01
Oral glycoprotein IIb/IIIa antagonists in coronary artery disease.
2001-01
Low-dose IGF-I has no selective advantage over insulin in regulating glucose metabolism in hyperglycemic depancreatized dogs.
2001-01
Neutrophils, not complement, mediate the mortality of experimental hemorrhagic pancreatitis.
2001-01
Viral markers and use of factor products among Finnish patients with bleeding disorders.
2001-01
Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function.
2001-01
Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon.
2001-01
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.
2001-01
Chronic hepatitis C in different populations: similar patterns of alanine aminotransferase alteration characterize similar clinical subgroups.
2001-01
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
2001-01
Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus-mediated gene transfer.
2001-01
Hepatic neovascularization after partial portal vein ligation: novel mechanism of chronic regulation of blood flow.
2001-01
Engineering the active site of ascorbate peroxidase.
2001-01
Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia.
2001-01
Epidermal growth factor reduces multiorgan failure induced by thioacetamide.
2001-01
Zaltoprofen prevents carbon tetrachloride-induced reduction of body weight in rats.
2001-01
Novel mutations in the GALK1 gene in patients with galactokinase deficiency.
2001
Is the Ala138Gly alteration of MEFV gene important for amyloidosis?
2001
Patents
Name Type Language
DL-ALANINE
FCC  
Preferred Name English
ALANINE, DL-
Systematic Name English
FEMA NO. 3818
Code English
DL-ALPHA-ALANINE
Common Name English
(R,S)-ALANINE
Common Name English
(±)-ALANINE
Systematic Name English
NSC-7602
Code English
DL-ALANINE [FCC]
Common Name English
(±)-2-AMINOPROPANOIC ACID
Systematic Name English
ALANINE DL-FORM [MI]
Common Name English
DL-.ALPHA.-AMINOPROPIONIC ACID
Common Name English
(±)-2-AMINOPROPIONIC ACID
Systematic Name English
Classification Tree Code System Code
CFR 21 CFR 172.540
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
JECFA EVALUATION DL-ALANINE
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
NCI_THESAURUS C29596
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
Code System Code Type Description
FDA UNII
1FU7983T0U
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
PUBCHEM
602
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
CAS
302-72-7
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
EPA CompTox
DTXSID6031255
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
RXCUI
1546161
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY RxNorm
NCI_THESAURUS
C61731
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
JECFA MONOGRAPH
1425
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
NSC
7602
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
DRUG CENTRAL
4306
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
MERCK INDEX
m1467
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
206-126-4
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY